                         SEQUENCE LISTING

<110>  TXP Pharma GmbH
 
<120>  W-peptide analogues

<130>  P3841PC00

<160>  11    

<170>  PatentIn version 3.5

<210>  1
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  W-peptide

<400>  1

Trp Lys Tyr Met Val Met 
1               5       


<210>  2
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Modified W-peptide


<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  Xaa is Orn

<400>  2

Trp Xaa Tyr Met Val Met 
1               5       


<210>  3
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Modified W-peptide

<400>  3

Trp Lys Tyr Met Pro Met 
1               5       


<210>  4
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Modified W-peptide

<400>  4

Trp Lys Tyr Ile Val Met 
1               5       


<210>  5
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Modified W-peptide

<400>  5

Trp Lys Phe Met Val Met 
1               5       


<210>  6
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Modified W-peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is Abu

<400>  6

Trp Lys Tyr Met Xaa Met 
1               5       


<210>  7
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Modified W-peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is Aib

<400>  7

Trp Lys Tyr Met Xaa Met 
1               5       


<210>  8
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Modified W-peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is independently any amino acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is independently any amino acid

<400>  8

Xaa Lys Tyr Xaa Val Met 
1               5       


<210>  9
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Modified W-peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is independently any amino acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is independently any amino acid

<400>  9

Xaa Lys Tyr Xaa Pro Met 
1               5       


<210>  10
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Modified W-peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is an amino acid having the structure R1R2C(NH2)-COOH, 
       wherein R1 is selected from -H, alkyl, alkenyl, cycloalkyl and 
       cycloalkenyl, and wherein R2 is selected from alkyl,alkenyl, 
       cycloalkyl and cycloalkenyl

<400>  10

Trp Lys Tyr Met Xaa Met 
1               5       


<210>  11
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Modified W-peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is Lys or Orn

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Tyr or Phe

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is Met or Ile

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is Val, Pro, Abu, Aib or an amino acid having the structure 
       R1R2C(NH2)-COOH, wherein R1 is -H, alkyl, alkenyl, cycloalkyl or 
       cycloalkenyl, and wherein R2 is alkyl, alkenyl, cycloalkyl or 
       cycloalkenyl

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Met or DMet

<400>  11

Trp Xaa Xaa Xaa Xaa Xaa 
1               5       


